BDBM571597 3-acetyl-1-(2-((1R,3S,5R)- 3-((6-bromo-3- methylpyridin-2- yl)carbamoyl)-5- ((dimethylamino)methyl)- 2-azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-N- (cyclopropylsulfonyl)-1H- indazole-6-carboxamide::US11447465, Cmp No. T-49

SMILES CN(C)C[C@]12C[C@H]1N([C@@H](C2)C(=O)Nc1nc(Br)ccc1C)C(=O)Cn1nc(C(C)=O)c2ccc(cc12)C(=O)NS(=O)(=O)C1CC1

InChI Key InChIKey=QHBAGVPKOMUNBT-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 571597   

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM571597(3-acetyl-1-(2-((1R,3S,5R)- 3-((6-bromo-3- methylpy...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent